Evidence map›Paper›PMID 15713648›Full record

ArticleMolecular and cellular biology2005

The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair.

Huimei Lu, Xu Guo, Xiangbing Meng, Jingmei Liu, Chris Allen, Justin Wray, Jac A Nickoloff, Zhiyuan Shen

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Roles of BCCIP deficiency in mammary tumorigenesis.Breast cancer research : BCR · 2017
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Expression pattern of BCCIP in hepatocellular carcinoma is correlated with poor prognosis and enhanced cell proliferation.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Huimei LuDepartment of Molecular Genetics and Microbiology, MSC08-4660, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA.
Xu Guo
Xiangbing Meng
Jingmei Liu
Chris Allen
Justin Wray
Jac A Nickoloff
Zhiyuan Shen
University of New Mexico · US

Funding

MAMMILIAN DOUBLE STRAND BREAK AND RECOMBINATIONAL REPAIRR01CA077693 · NCI · UNIVERSITY OF NEW MEXICO · PI OSLEY, MARY ANN · 1999 to 2008
$2.4M
Transcription-enhanced recombination in mammalian cellsR01ES008353 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI SHEN, ZHIYUAN · 2003 to 2006
$1.0M
ROLES OF UBIQUITIN CONJUGATING ENZYMES IN DNA REPAIRR29ES008353 · NIEHS · UNIVERSITY OF NEW MEXICO · PI SHEN, ZHIYUAN · 1997 to 2001
$214k
NCI NIH HHS CA77693NCI NIH HHS R01 CA077693NIEHS NIH HHS ES08353NIEHS NIH HHS R01 ES008353NIEHS NIH HHS R29 ES008353
6 · The paper itself

Abstract

Homologous recombinational repair (HRR) of DNA damage is critical for maintaining genome stability and tumor suppression. RAD51 and BRCA2 colocalization in nuclear foci is a hallmark of HRR. BRCA2 has important roles in RAD51 focus formation and HRR of DNA double-strand breaks (DSBs). We previously reported that BCCIPalpha interacts with BRCA2. We show that a second isoform, BCCIPbeta, also interacts with BRCA2 and that this interaction occurs in a region shared by BCCIPalpha and BCCIPbeta. We further show that chromatin-bound BRCA2 colocalizes with BCCIP nuclear foci and that most radiation-induced RAD51 foci colocalize with BCCIP. Reducing BCCIPalpha by 90% or BCCIPbeta by 50% by RNA interference markedly reduces RAD51 and BRCA2 foci and reduces HRR of DSBs by 20- to 100-fold. Similarly, reducing BRCA2 by 50% reduces RAD51 and BCCIP foci. These data indicate that BCCIP is critical for BRCA2- and RAD51-dependent responses to DNA damage and HRR.

Indexed as

BRCA2 ProteinCalcium-Binding ProteinsCell Cycle ProteinsCell NucleusCells, CulturedDNA-Binding ProteinsDNA DamageDNA RepairHumansNuclear ProteinsProtein Interaction MappingProtein IsoformsRad51 RecombinaseRecombination, GeneticRNA InterferenceRNA, Small InterferingBCCIP protein, humanBRCA2 ProteinCalcium-Binding ProteinsCell Cycle ProteinsDNA-Binding ProteinsNuclear ProteinsProtein IsoformsRAD51 protein, humanRad51 RecombinaseRNA, Small Interfering

Identifiers

PMID15713648
PMCPMC549367
OpenAlexW2146444679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.